ATE354373T1 - Verabreichung von gammaglobulinen zur behandlung von lymphomen - Google Patents

Verabreichung von gammaglobulinen zur behandlung von lymphomen

Info

Publication number
ATE354373T1
ATE354373T1 AT00964595T AT00964595T ATE354373T1 AT E354373 T1 ATE354373 T1 AT E354373T1 AT 00964595 T AT00964595 T AT 00964595T AT 00964595 T AT00964595 T AT 00964595T AT E354373 T1 ATE354373 T1 AT E354373T1
Authority
AT
Austria
Prior art keywords
preparation
methods
ivig
gammaglobulins
lymphomas
Prior art date
Application number
AT00964595T
Other languages
English (en)
Inventor
Yehuda Shoenfeld
Pnina Fishman
Original Assignee
Arp Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arp Biomed Ltd filed Critical Arp Biomed Ltd
Application granted granted Critical
Publication of ATE354373T1 publication Critical patent/ATE354373T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00964595T 1999-09-27 2000-09-27 Verabreichung von gammaglobulinen zur behandlung von lymphomen ATE354373T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40505099A 1999-09-27 1999-09-27

Publications (1)

Publication Number Publication Date
ATE354373T1 true ATE354373T1 (de) 2007-03-15

Family

ID=23602082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964595T ATE354373T1 (de) 1999-09-27 2000-09-27 Verabreichung von gammaglobulinen zur behandlung von lymphomen

Country Status (7)

Country Link
EP (1) EP1220687B1 (de)
AT (1) ATE354373T1 (de)
AU (1) AU7551700A (de)
DE (1) DE60033540D1 (de)
HK (1) HK1049608A1 (de)
TW (1) TWI248819B (de)
WO (1) WO2001022996A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin

Also Published As

Publication number Publication date
WO2001022996A1 (en) 2001-04-05
HK1049608A1 (zh) 2003-05-23
EP1220687B1 (de) 2007-02-21
DE60033540D1 (de) 2007-04-05
EP1220687A1 (de) 2002-07-10
AU7551700A (en) 2001-04-30
TWI248819B (en) 2006-02-11

Similar Documents

Publication Publication Date Title
MY112405A (en) Method of tumer treatment.
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
ATE186219T1 (de) Kombination von antihormonale und bindende moleküle zur krebsbehandlung
BR0209147A (pt) Terapia combinada que usa anticorpos anti-egfr e agentes anti-hormonais
JP2007523862A5 (de)
WO2004068931A3 (en) Amphiregulin antibodies and their use to treat cancer and psoriasis
WO2002017852A3 (en) Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
DE602004025726D1 (de) Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
BR9507067A (pt) Processo imunoterapêutico de tratamento de doenças cancerosas pro administração de gama-globulinas
ATE485818T1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
BR9808263A (pt) Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
WO2004056971A3 (en) Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
ATE354373T1 (de) Verabreichung von gammaglobulinen zur behandlung von lymphomen
WO2000006136A3 (en) Therapeutic combination of polyamine with an anticancer agent
WO2002074756A3 (de) Urokinase-inhibitoren
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
EA200600987A1 (ru) Применение сирамезина в лечении злокачественных опухолей
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
BR0315087A (pt) Métodos para a produção de um efeito de dano vascular em um animal de sangue quente e para o tratamento de câncer envolvendo um tumor sólido em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6126 ou um sal deste farmaceuticamente aceitável e gencitabina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties